University of Nottingham

University of Nottingham

Pre-Clinical Oncology

Research in the Division is translational and involves strong collaborations with clinicians and industry. Current research areas include: use of reporter constructs for the imaging of key biological parameters within tumours, such as growth, apoptosis, angiogenesis and metastatic pathways and stem cell evolution; modelling the tumour microenvironment including the process of epithelial-mesenchymal transition; analysis of paracrine interactions in tumour progression including HGF/c-met, hedgehog, and fibroblast growth factors; delivery of siRNAs using non-viral and viral delivery systems for target validation; pre-clinical validation/target identification of traditional Chinese medicines; contribution of ß-catenin controlled intestinal stem-cell associated homeodomain transcription factors to carcinogenesis and the involvement of the tumour suppressor gene, FBW7 a ubiquitin ligase, in intestinal malignant progression.

Entry requirements

Candidates applying to join MPhil or other research Masters programmes (e.g. MRes, MA/MSc (by research) would normally be expected to hold an Honours degree at 2.2 level or above (or international equivalent) in an appropriate subject; candidates are generally required to submit a research proposal with their applications; International English Language Testing System (IELTS) 6.0 with no less than 5 in any 1 element; Test of English as a Foreign Language (TOEFL): paper version: 550 with a minimum of 4.0 in the Test of Written English (TWE); Internet-based version: 79 with no less than 17 in any 1 element.


Qualification Study mode Start month Fee Course duration
MRes Full-time September 2016 - 2 years
MRes Part-time September 2016 - 4 years

Campus details

Campus name Town Postcode Region Main campus Campus Partner
Queen's Medical Centre Nottingham NG7 2HA East Midlands

Key information

Postgraduate Enquiry Team
Telephone number: 
0115 951 5559